Drug Search Results
More Filters [+]

Policapram

Alternative Names: policapram, nylon, b-300, silon
Latest Update: 2025-03-12
Latest Update Note: News Article

Product Description

Mechanisms of Action: M3 Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Nasal,Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Chile | Colombia | Dominican Republic | Germany | India | Jordan | Pakistan | South Africa | Sweden | Taiwan | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Hadassah Medical Organization
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Policapram

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Stroke

Phase 1: Type 1 Diabetes

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

STUDY00002251

N/A

Recruiting

Low Back Pain|Pain, Postoperative

2026-12-01

ChiCTR2400084109

N/A

Not yet recruiting

Gingivitis

2026-06-06

STUDY00019465

N/A

Enrolling by invitation

Inflammation|Pain, Postoperative|Surgical Wound Infection

2025-12-31

NCT03674151

N/A

Recruiting

Burns Unspecified

2025-12-01

Recent News Events